Data interoperability in healthcare means that different computer systems and programs—like Electronic Health Records (EHRs), lab systems, imaging, and pharmacy software—can access, share, and use patient data together in a smooth way. In the United States, healthcare data is often separated and stored in different places. This makes it harder to give patients good care and manage operations well. Older computer systems and separate data storage in departments stop easy sharing of information between hospitals, pharmacies, and drug companies.
One big problem is old technology. Many hospitals and clinics use software that was not made to work with other systems. These “legacy systems” work on their own and block easy sharing of patient information. This makes it hard for health managers and IT staff to share data quickly. When patient records are not fully available fast, it can harm how doctors diagnose illnesses, plan treatment, or manage medicines.
Another issue is the rules to keep patient information safe. Laws like the Health Insurance Portability and Accountability Act (HIPAA) require data to be protected with encryption, strict access control, and tracking. Making sure the data is safe can limit sharing if the systems cannot support safe methods of exchanging data.
To break down separated data, health care uses special data sharing methods to make systems work together. One important standard is Fast Healthcare Interoperability Resources (FHIR). FHIR lets health data be shared in small parts that can be quickly accessed and used on many platforms like telemedicine or patient apps. This is useful in the U.S. where care happens at many different places.
Other key standards include HL7, which sets rules for how health data messages are sent; DICOM for medical images; and LOINC for lab tests and reports. These standards help different systems format and understand health data consistently.
Many healthcare groups in the U.S. use cloud storage and Application Programming Interface (API) technology to let data move securely and in real time. Medical practice managers and IT leaders use software made for their specific needs. These tools help older systems and new platforms work together without changing everything.
Vinod Subbaiah, founder of Asahi Technologies, explains how custom software can join old and new systems while following HIPAA rules. It includes encryption, multi-factor login, and access controls by role. Combining technology and strong data handling helps break data silos and allows better patient care.
Healthcare providers and drug companies need to work together to create and deliver good medicines. This teamwork depends on sharing clear and standard data. Sharing data helps researchers find patients for clinical trials faster. It also helps doctors give better treatments based on new drug studies and clinical information.
Good data sharing is important for diagnosing hard cases and fixing wrong patient records. For example, Pangaea Data, an AI company, built a system that works with groups like the UK’s National Health Service (NHS) and drug companies. Their system finds patients with difficult diseases, like cancer cachexia, by looking at many patient records. It found many more patients than usual methods. This helped reduce treatment costs and saved lots of money for NHS.
Even though this example is from the UK, similar technology can help U.S. health care. Using Microsoft Azure and FHIR keeps patient records safe and private, which is very important for U.S. administrators and IT staff.
Collaboration also helps drug companies. They can find more patients for trials, develop medicines faster, and learn more about patients. This leads to quicker approvals and better treatments.
Artificial Intelligence (AI) is changing how healthcare and drug companies work together. It helps automate tasks and improve data handling. AI tools quickly gather and sort important patient information from large health databases.
In busy medical offices in the U.S., AI tools like Simbo AI help by handling phone calls and appointment scheduling. This eases the workload on staff and improves patient communication by reducing missed calls.
AI also helps with clinical trials by checking if patients qualify, monitoring patients, and tracking any side effects. Advanced AI can help doctors by writing reports and analyzing data faster than people can. This speeds up drug development and helps include patients who might otherwise be left out.
According to SAS, a company that studies AI, automation will change clinical work. Doctors and nurses will spend less time on paperwork and more time with patients. This will make healthcare better for both. Public health and insurance groups will also use AI to share data quickly and work together to improve health for many people.
Even with AI and new data-sharing rules, many U.S. healthcare groups still use outdated systems. Updating these systems needs money and planning. Steve Kearney, Global Medical Director at SAS, says healthcare must improve their systems by focusing on clean, useful, and safe data to get full benefit from AI.
Medical practice owners need to look at their current Electronic Health Record systems and data tools. They should think about cost, following rules like HIPAA, and the 21st Century Cures Act. This act pushes for patient access to their own data and better data sharing among certified technology.
As health providers upgrade, they will rely more on cloud solutions and unified data plans. These reduce data silos and help share data correctly. Better systems improve diagnosis, cut mistakes, and lower costs by speeding up communication and decisions.
By using ideas from groups like SAS, Asahi Technologies, and Pangaea Data, healthcare leaders in the U.S. can learn what tools and methods help fix data sharing problems. This will improve how well operations run, help doctors give better care, and support AI’s growing role in healthcare and drug development teamwork.
This clear approach shows what digitizing healthcare looks like in the U.S. It offers medical managers and IT teams a path to safely and successfully add interoperable systems to their work.
SAS forecasts a steady transformation in healthcare and life sciences, driven by focused efforts toward AI integration, modernization of technology, and active patient engagement.
AI-driven insights will be implemented across patient care personalization and drug development, focusing on governance and regulations to ensure effective integration.
Generative AI will facilitate high-quality information extraction in clinical trials, leading to faster submissions and inclusion of underserved populations.
Pharma and healthcare will converge fundamentally, utilizing shared data to enhance patient care and treatment methodologies while overcoming data interoperability challenges.
Many healthcare technologies remain outdated, necessitating a digital overhaul to modernize and integrate systems, which requires substantial financial investment.
AI-driven analytics will strengthen communications between payers and public health, enabling better collaboration through real-time data exchanges and shared accountability.
Patients will demand smarter health tech applications that utilize their data, facilitated by regulations allowing secure cross-border data exchange.
Robust data management will be essential due to increasing data complexity and regulatory requirements; organizations will leverage cloud-based platforms to enhance connectivity and productivity.
AI and natural language processing will automate repetitive tasks in clinical settings, improving efficiency and allowing clinicians to focus more on direct patient care.
Government agencies will adopt successful innovations from around the world, utilizing analytic technologies to enhance disease detection and model predicting health threats strategically.